Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jose-Maria Fernandez

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Cardiovascular Medicine|November 24, 2025
Effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction: a narrative review of real-world evidence studiesCarlos Escobar, Pedro Caravaca-Pérez, Jose Maria Fernandez Rodriguez, et al.
Obesity Surgery|March 25, 2025
Glucose Homeostasis Improvement After Single Anastomosis Duodenojejunal Bypass with Sleeve Gastrectomy in Goto-Kakizaki RatsSirio Melone, Jose Maria Fernandez-Cebrian, Mario Amores, et al.
Genes, Chromosomes & Cancer|November 7, 2024
Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13)Anders Östlund, Ahmed Waraky, Anna Staffas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2024
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual DiseaseAnne Tierens, Nira Arad-Cohen, Daniel Cheuk, et al.
Expert Review of Anticancer Therapy|October 3, 2022
Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortiumNira Arad-Cohen, Bernward Zeller, Jonas Abrahamsson, et al.
British Journal of Haematology|August 19, 2025
Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO-DBH AML studyMorten Krogh Herlin, Eigil Kjeldsen, Jonas Abrahamsson, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 24, 2023
Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institutionFelipe A Calvo, Jacobo Palma, Javier Serrano, et al.
Bone Marrow Transplantation|June 3, 2025
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMTKatia Perruccio, Katherine N Ward, Gloria Tridello, et al.
Trials|June 19, 2026
CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortiumGertjan J L Kaspers, Merlijn van Hamel, Jonas Abrahamsson, et al.
Cell|November 19, 2016
Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune CellsLu Chen, Bing Ge, Francesco Paolo Casale, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
Frontiers in Cardiovascular Medicine|November 24, 2025
Effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction: a narrative review of real-world evidence studiesCarlos Escobar, Pedro Caravaca-Pérez, Jose Maria Fernandez Rodriguez, et al.
Obesity Surgery|March 25, 2025
Glucose Homeostasis Improvement After Single Anastomosis Duodenojejunal Bypass with Sleeve Gastrectomy in Goto-Kakizaki RatsSirio Melone, Jose Maria Fernandez-Cebrian, Mario Amores, et al.
Genes, Chromosomes & Cancer|November 7, 2024
Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13)Anders Östlund, Ahmed Waraky, Anna Staffas, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|April 11, 2024
Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual DiseaseAnne Tierens, Nira Arad-Cohen, Daniel Cheuk, et al.
Expert Review of Anticancer Therapy|October 3, 2022
Supportive care in pediatric acute myeloid leukemia:Expert-based recommendations of the NOPHO-DB-SHIP consortiumNira Arad-Cohen, Bernward Zeller, Jonas Abrahamsson, et al.
British Journal of Haematology|August 19, 2025
Characteristics and prognosis of paediatric normal karyotype acute myeloid leukaemia: A NOPHO-DBH AML studyMorten Krogh Herlin, Eigil Kjeldsen, Jonas Abrahamsson, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 24, 2023
Hospital-based proton therapy implementation during the COVID pandemic: early clinical and research experience in a European academic institutionFelipe A Calvo, Jacobo Palma, Javier Serrano, et al.
Bone Marrow Transplantation|June 3, 2025
Clinical characteristic and outcome of HHV-6 encephalitis after allogeneic hematopoietic cell transplantation: A study of Infectious Disease Working Party of EBMTKatia Perruccio, Katherine N Ward, Gloria Tridello, et al.
Trials|June 19, 2026
CHIP-AML22: a complex clinical trial in de novo pediatric AML patients, including a gemtuzumab ozogamicin randomization and targeted therapy with quizartinib in eligible subgroups, within the NOPHO-DB-SHIP consortiumGertjan J L Kaspers, Merlijn van Hamel, Jonas Abrahamsson, et al.
Cell|November 19, 2016
Genetic Drivers of Epigenetic and Transcriptional Variation in Human Immune CellsLu Chen, Bing Ge, Francesco Paolo Casale, et al.
Pageof 2